Q: What could be the clinical applications of the radiomics software?

Q: What could be the clinical applications of the radiomics software?

The main advantage, at the moment, would be for inoperable non-metastatic non-small cell lung cancer, which is known to be a very prominent disease. We know that the TNM classification, which is the base of all the existing guidelines, is not predictive at all to make the crucial decision between palliative and curative treatment. For example, there are T4 and N3 patients with good prognosis that could be selected for curative treatment even though the guidelines propose a palliative treatment. We also see a clear indication for the growing elderly population, which are usually undertreated, for which we could help to select patients with good prognosis without extra invasive maneuvers. In short, this non-invasive radiomics tool could help the multidisciplinary team to make decisions in the treatment of inoperable non-small cell lung cancer and more specifically help to avoid under treatment.